Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 1;48(3):228-232.
doi: 10.1097/RLU.0000000000004540. Epub 2023 Jan 14.

The Role of 68 Ga-FAPI PET/CT in Detection of Metastatic Lobular Breast Cancer

Affiliations

The Role of 68 Ga-FAPI PET/CT in Detection of Metastatic Lobular Breast Cancer

Yael Eshet et al. Clin Nucl Med. .

Abstract

Purpose: Invasive lobular breast cancer (ILC) may be hard to detect using conventional imaging modalities and usually shows less avidity to 18 F-FDG PET/CT. 68 Ga-fibroblast activation protein inhibitor (FAPI) PET/CT has shown promising results in detecting non- 18 F-FDG-avid cancers. We aimed to assess the feasibility of detecting metastatic disease in patients with non- 18 F-FDG-avid ILC.

Methods: This prospective study included patients with metastatic ILC, infiltrative to soft tissues, which was not 18 F-FDG avid. The patients underwent 68 Ga-FAPI PET/CT for evaluation, which was correlated with the fully diagnostic CT performed at the same time.

Results: Seven women (aged 57 ± 10 years) were included. Among the 30 organs and structures found to be involved by tumor, the number of findings observed by FAPI PET/CT was significantly higher than that observed by CT alone ( P = 0.022), especially in infiltrative soft tissue and serosal locations.

Conclusions: This small pilot trial suggests a role for 68 Ga-FAPI PET/CT in ILC, which needs to be confirmed by subsequent trials.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest and sources of funding: The authors declare that they have no conflicts of interest. Funding (of radiotracer and PET/CT services) was provided by Sheba Medical Center internal research fund Isotopia Molecular Imaging Ltd.

References

    1. Thomas M, Kelly ED, Abraham J, et al. Invasive lobular breast cancer: a review of pathogenesis, diagnosis, management, and future directions of early stage disease. Semin Oncol . 2019;46:121–132.
    1. Harris M, Howell A, Chrissohou M, et al. A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer . 1984;50:23–30.
    1. Lopez JK, Bassett LW. Invasive lobular carcinoma of the breast: spectrum of mammographic, US, and MR imaging findings. Radiographics . 2009;29:165–176.
    1. Nazareno J, Taves D, Preiksaitis H-G. Metastatic breast cancer to the gastrointestinal tract: a case series and review of the literature. World J Gastroenterol . 2006;12:6219–6224.
    1. Korhonen T, Kuukasjärvi T, Huhtala H, et al. The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients. Breast . 2013;22:1119–1124.

LinkOut - more resources